Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

High-Intensity Statin Use and LDL-C Control

J Clin Lipidol; ePub 2018 Apr 26; Lamprecht Jr, et al

Guideline-directed use of high-intensity statin therapy (HIST) significantly increased over the past 10 years and coincided with decreased population low-density lipoprotein cholesterol (LDL-C) levels among adults with atherosclerotic cardiovascular disease (ASCVD) enrolled in clinical pharmacy cardiac risk reduction service. The cross-sectional studies were performed over time, comprised of 18,006 adults with both acute and chronic ASCVD, to assess trends in statin use and LDL-C levels from 2007 to 2016. Researchers found:

  • The use of statin therapy (any intensity) remained relatively consistent throughout the study period.
  • The proportion of patients receiving HIST increased to a peak of 67%.
  • Use of prescription non-statin lipid-lowering therapy decreased from 25% to 2%.
  • The proportion of patients achieving LDL-C <70 mg/dL increased from 39% to 54%.

Citation:

Lamprecht Jr DG, Shaw PB, King JB, Hogan K, Olson KL. Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service. [Published online ahead of print April 26, 2018]. J Clin Lipidol. doi:10.1016/j.jacl.2018.04.007.

This Week's Must Reads

Detection & Management of Resistant Hypertension, Hypertension; ePub 2018 Sep 13; Carey, et al

Does Aspirin Prevent CV Events in Older Adults?, N Engl J Med; ePub 2018 Sep 16; McNeil, et al

Timing of ICD Placement From Last Hospitalization for HF, Circulation; ePub 2018 Sep 13; Ambrosy, et al

FFR and Quality of Life After PCI, Circulation; ePub 2018 Sep 18; Nishi, et al

VTE risk for continuous cycle oral contraceptives, Li J et al. JAMA Intern Med. 2018 Oct 1. doi:10.1001/jamainternmed.2018.4251

Must Reads in Hypercholesterolemia

Racial Differences in Statin Use, JAMA Cardiol; ePub 2018 Jun 13; Nanna, et al

LLT Use in Patients with Elevated LDL-C, Circ Cardiovasc Qual Outcomes; ePub 2018 May 10; Virani, et al

Evolocumab in Differing Patient Populations , J Pharmacokinet Pharmacodyn; ePub 2018 May 7; Kuchimanchi, et al

LDL-C Targets in Elderly Statin Users After ACS, J Am Heart Assoc; ePub 2018 May 12; Alter, et al

Patient Perspectives on Statin Therapy, Clin Cardiol; ePub 2018 May 10; Brinton